JP2006513990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513990A5 JP2006513990A5 JP2004540030A JP2004540030A JP2006513990A5 JP 2006513990 A5 JP2006513990 A5 JP 2006513990A5 JP 2004540030 A JP2004540030 A JP 2004540030A JP 2004540030 A JP2004540030 A JP 2004540030A JP 2006513990 A5 JP2006513990 A5 JP 2006513990A5
- Authority
- JP
- Japan
- Prior art keywords
- ifn
- therapeutic agent
- use according
- administered
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41430702P | 2002-09-27 | 2002-09-27 | |
| PCT/US2003/030532 WO2004028472A2 (en) | 2002-09-27 | 2003-09-26 | THERAPIES FOR CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY USING INTERFERON-β |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006250090A Division JP2007039463A (ja) | 2002-09-27 | 2006-09-14 | インターフェロンβを用いる慢性炎症性脱髄性多発性ニューロパシーの治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006513990A JP2006513990A (ja) | 2006-04-27 |
| JP2006513990A5 true JP2006513990A5 (cg-RX-API-DMAC7.html) | 2006-11-09 |
Family
ID=32043377
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004540030A Pending JP2006513990A (ja) | 2002-09-27 | 2003-09-26 | インターフェロンβを用いる慢性炎症性脱髄性多発性ニューロパシーの治療 |
| JP2006250090A Pending JP2007039463A (ja) | 2002-09-27 | 2006-09-14 | インターフェロンβを用いる慢性炎症性脱髄性多発性ニューロパシーの治療 |
| JP2011023226A Withdrawn JP2011132248A (ja) | 2002-09-27 | 2011-02-04 | インターフェロンβを用いる慢性炎症性脱髄性多発性ニューロパシーの治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006250090A Pending JP2007039463A (ja) | 2002-09-27 | 2006-09-14 | インターフェロンβを用いる慢性炎症性脱髄性多発性ニューロパシーの治療 |
| JP2011023226A Withdrawn JP2011132248A (ja) | 2002-09-27 | 2011-02-04 | インターフェロンβを用いる慢性炎症性脱髄性多発性ニューロパシーの治療 |
Country Status (21)
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1575531T3 (da) * | 2002-09-27 | 2011-11-21 | Biogen Idec Inc | Terapier for kronisk inflammatorisk demyeliniserende polyneuropati under anvendelse af interferon-beta |
| TW200633718A (en) * | 2004-12-16 | 2006-10-01 | Applied Research Systems | Treatment of hepatitis c in the asian population |
| WO2008130382A2 (en) | 2006-10-31 | 2008-10-30 | East Carolina University | Fusion proteins comprising an anti -inflammatory cytokine and an antigen for treatment of immune disorders |
| WO2010117848A1 (en) | 2009-03-31 | 2010-10-14 | East Carolina University | Cytokines and neuroantigens for treatment of immune disorders |
| IN2014CN02982A (cg-RX-API-DMAC7.html) * | 2011-10-01 | 2015-07-03 | Glytech Inc | |
| GB201212878D0 (en) | 2012-07-20 | 2012-09-05 | Pike Justin | Authentication method and system |
| EP3072513A1 (en) | 2015-03-26 | 2016-09-28 | Medday | Biotin for treating Amyotrophic lateral sclerosis |
| GB201520741D0 (en) | 2015-05-27 | 2016-01-06 | Mypinpad Ltd And Licentia Group Ltd | Authentication methods and systems |
| WO2020009437A1 (ko) * | 2018-07-04 | 2020-01-09 | 서울대학교산학협력단 | 신경손상의 면역세포치료 |
| GB201916441D0 (en) | 2019-11-12 | 2019-12-25 | Mypinpad Ltd | Computer-implemented system and method |
| WO2026010306A1 (ko) * | 2024-07-02 | 2026-01-08 | 주식회사 카인사이언스 | 탈수초 질환 치료를 위한 펩타이드 및 ivig의 병용 요법 |
| KR20260005781A (ko) * | 2024-07-02 | 2026-01-12 | 주식회사 카인사이언스 | 만성 염증성 탈수초 다발신경병증에 대한 펩타이드의 투여요법 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3572982D1 (en) * | 1984-03-06 | 1989-10-19 | Takeda Chemical Industries Ltd | Chemically modified lymphokine and production thereof |
| ZA878295B (en) * | 1986-11-06 | 1988-05-03 | Amarillo Cell Culture Co. Inc. | Treatment of immuno-resistant disease |
| DE3712564A1 (de) * | 1987-04-14 | 1988-11-24 | Bioferon Biochem Substanz | Verfahren zur konstruktion einer animalen zellinie fuer die herstellung von humanem interferon-beta |
| DE4128319A1 (de) * | 1991-08-27 | 1993-03-04 | Bioferon Biochem Substanz | Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen |
| US5545723A (en) * | 1994-03-15 | 1996-08-13 | Biogen Inc. | Muteins of IFN-β |
| IL113280A (en) * | 1994-04-12 | 2004-12-15 | Res Dev Foundation | A preparation for the treatment of self-immunization diseases with the help of interferon of one type |
| ZA952797B (en) * | 1994-04-12 | 1996-10-07 | Res Dev Foundation | Method of treating auto-immune diseases using type one interferons |
| TW403653B (en) * | 1995-12-25 | 2000-09-01 | Otsuka Pharma Co Ltd | Dry compositions |
| AU766190B2 (en) * | 1998-10-16 | 2003-10-09 | Biogen Idec Ma Inc. | Interferon-beta fusion proteins and uses |
| DK1656952T3 (da) * | 1998-10-16 | 2014-01-20 | Biogen Idec Inc | Polyalkylenglycolkonjugater af interferon beta-1A og anvendelser deraf |
| US6419934B1 (en) * | 1999-02-24 | 2002-07-16 | Edward L. Tobinick | TNF modulators for treating neurological disorders associated with viral infection |
| WO2000050620A2 (en) * | 1999-02-26 | 2000-08-31 | Human Genome Sciences, Inc. | Human endokine alpha and methods of use |
| US6531122B1 (en) * | 1999-08-27 | 2003-03-11 | Maxygen Aps | Interferon-β variants and conjugates |
| WO2002036628A2 (en) * | 2000-11-02 | 2002-05-10 | Maxygen Aps | New multimeric interferon beta polypeptides |
| EP1366075B1 (en) * | 2001-02-27 | 2009-05-27 | Maxygen Aps | New interferon beta-like molecules |
| US20030091544A1 (en) * | 2001-03-13 | 2003-05-15 | Vical Incorporated | Interferon-Beta polynucleotide therapy for autoimmune and inflammatory diseases |
| DK1575531T3 (da) * | 2002-09-27 | 2011-11-21 | Biogen Idec Inc | Terapier for kronisk inflammatorisk demyeliniserende polyneuropati under anvendelse af interferon-beta |
-
2003
- 2003-09-26 DK DK03798770.8T patent/DK1575531T3/da active
- 2003-09-26 KR KR1020057005145A patent/KR20050059195A/ko not_active Ceased
- 2003-09-26 AU AU2003277006A patent/AU2003277006C1/en not_active Ceased
- 2003-09-26 CN CN201010256064XA patent/CN102038938A/zh active Pending
- 2003-09-26 JP JP2004540030A patent/JP2006513990A/ja active Pending
- 2003-09-26 WO PCT/US2003/030532 patent/WO2004028472A2/en not_active Ceased
- 2003-09-26 AT AT03798770T patent/ATE520412T1/de not_active IP Right Cessation
- 2003-09-26 MX MXPA05003243A patent/MXPA05003243A/es not_active Application Discontinuation
- 2003-09-26 NZ NZ565990A patent/NZ565990A/en not_active IP Right Cessation
- 2003-09-26 GE GEAP20038765A patent/GEP20094699B/en unknown
- 2003-09-26 UA UAA200503909A patent/UA86749C2/ru unknown
- 2003-09-26 US US10/529,522 patent/US20060182715A1/en not_active Abandoned
- 2003-09-26 EP EP03798770A patent/EP1575531B9/en not_active Expired - Lifetime
- 2003-09-26 CA CA002500189A patent/CA2500189A1/en not_active Abandoned
- 2003-09-26 BR BR0314548-4A patent/BR0314548A/pt not_active IP Right Cessation
- 2003-09-26 RS YUP-2005/0255A patent/RS20050255A/sr unknown
- 2003-09-26 EA EA200500545A patent/EA009289B1/ru not_active IP Right Cessation
- 2003-09-26 PL PL377612A patent/PL377612A1/pl unknown
- 2003-09-26 CN CNA038253720A patent/CN1802170A/zh active Pending
-
2005
- 2005-03-15 IS IS7746A patent/IS7746A/is unknown
- 2005-03-23 ZA ZA200502416A patent/ZA200502416B/en unknown
- 2005-04-27 NO NO20052059A patent/NO20052059L/no not_active Application Discontinuation
-
2006
- 2006-09-14 JP JP2006250090A patent/JP2007039463A/ja active Pending
-
2010
- 2010-11-11 US US12/944,396 patent/US20120058083A1/en not_active Abandoned
-
2011
- 2011-02-04 JP JP2011023226A patent/JP2011132248A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011132248A (ja) | インターフェロンβを用いる慢性炎症性脱髄性多発性ニューロパシーの治療 | |
| JP4883665B2 (ja) | インターフェロン−βを使用する腎不全のための治療法 | |
| CN100480266C (zh) | 干扰素-β融合蛋白及用途 | |
| ES2365000T3 (es) | Nuevas composiciones químicamente modificadas de proteína que estimulan eritropoyetina y métodos. | |
| JP2024105721A (ja) | 炎症性疾患および自己免疫疾患の処置の組成物および方法 | |
| JP2002527100A5 (cg-RX-API-DMAC7.html) | ||
| HK1141998A (en) | THERAPIES FOR RENAL FAILURE USING INTERFERON-β |